Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trial
- 372 Downloads
Osteoarthritis (OA) is one of the most common articular disorders. Many patients do not respond to acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), the mainstay of pharmacotherapy for knee OA. The plants Elaeagnus angustifolia and Boswellia thurifera have anti-inflammatory and analgesic properties. This study aimed to evaluate the effect of E. angustifolia alone and in combination with B. thurifera compared with ibuprofen in patients with knee osteoarthritis. In a randomized double-blind controlled clinical trial, 75 patients with knee OA were randomly and equally assigned to one of three groups Elaeagnus (n = 23), Elaeagnus/Boswellia (n = 26), and ibuprofen (n = 26) to receive the capsules of Elaeagnus, Elaeagnus/Boswellia, and ibuprofen, respectively, three times daily with meals for 4 weeks. Pain severity based on VAS (visual analog scale, 0 to 10 scale) and the scores of LPFI (Lequesne Pain and Function Index) and PGA (patient global assessment) were determined pre- and post-intervention for all patients. All interventions had significant lowering effects on VAS, LPFI, and PGA scores (P < 0.001 for all parameters) with no significant difference between groups in terms of effects on all evaluated parameters. Consumption of E. angustifolia fruit extract either alone or in combination with Boswellia oleo-gum resin extract could decrease pain and improve function in patients with knee osteoarthritis comparable to ibuprofen.
KeywordsBoswellia thurifera Clinical trial Elaeagnus angustifolia Ibuprofen Knee osteoarthritis
This study was financially supported by Barij Essence Pharmaceutical Company, Kashan, Iran. The authors would like to acknowledge the staff of Barij Essence Company and Rheumatology Clinic of Alzahra Hospital for their assistance.
Compliance with ethical standards
- 3.Altman RD (2010) Early management of osteoarthritis. Am J Manag Care 16 Suppl Management:S41–47.Google Scholar
- 7.Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64(4):465–474CrossRefGoogle Scholar
- 13.Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Arthritis Rheum 29(8):1039–1049PubMedGoogle Scholar
- 20.Farahbakhsh S, Arbabian S, Emami F, Rastegar Moghadam B, Ghoshooni H, Noroozzadeh A et al (2011) Inhibition of cyclooxygenase type 1 and 2 enzyme by aqueous extract of Elaeagnus angustifolia in mice. Basic Clin Neurosci 2(2):31–37Google Scholar
- 21.Maghzi M, Khorsandi L, Orazizadeh M, Ahmadi K (2015) Histological effects of Elaeagnus angustifolia aqueous extract on cartilage degradation in experimental osteoarthritis. Asian J Phytomed Clin Res 3(2):50–54Google Scholar
- 22.Cansev A, Sahan Y, Celik G, Taskesen S, Ozbey H (2011) Chemical properties and antioxidant capacity of Elaeagnus angustifolia L fruits. Asian J Chem 23(6):2661–2665Google Scholar
- 25.Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Müller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CF (2006) Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol 290(6):G1131–G1137CrossRefPubMedGoogle Scholar